Activity of Ertapenem (MK-0826) versus Enterobacteriaceae with Potent β-Lactamases

Ertapenem (MK-0826; L-749,345), a new carbapenem with a long serum half-life, was tested, in vitro, against β-lactamase-producing bacteria. The new compound had a MIC at which 90% of the isolates were inhibited of 0.06 μg/ml for extended-spectrum β-lactamase (ESBL)-producing klebsiellas, compared wi...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Livermore, David M., Oakton, Karen J., Carter, Michael W., Warner, Marina
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2001
主題:	Susceptibility
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90739/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11557477/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.10.2831-2837.2001
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!